#USA #healthcare #Quest Diagnostics #Secaucus #DGX

Quest Diagnostics Achieves Fortune Recognition

In a proud achievement, Quest Diagnostics (NYSE: DGX), a premier provider of diagnostic information services, has been honored as one of the World’s Most Admired Companies in Fortune® magazine for the twelfth consecutive year. The announcement, made on January 21, 2026, signifies Quest's sustained commitment to excellence in the healthcare sector.

Commitment to Purpose

Jim Davis, the Chairman, CEO, and President of Quest Diagnostics, stated, "This recognition is a testament to the dedication of our 55,000 employees. Every day, they work together towards our shared purpose of creating a healthier world, one life at a time." His comments reflect the company's ethos and the impact of its services in the field of diagnostics.

Ranking in the Industry

In addition to its overall recognition, Quest Diagnostics received accolades as the second-ranked company in the Health Care Pharmacy and Other Services category. This achievement underscores its pivotal role within the healthcare landscape, particularly in delivering diagnostic insights that aid in better health outcomes.

Understanding the Recognition

The prestigious Fortune World's Most Admired Companies list is compiled based on nine essential attributes that reflect corporate reputation. These include product and service quality, innovation, long-term financial value, and a company's commitment to social, environmental, and community responsibilities, as well as effective people management. To gather insights, Fortune partnered with the consulting firm Korn Ferry to survey thousands of executives, board members, and analysts from various sectors, analyzing nearly 700 firms. A company must rank in the top half of its industry survey to qualify for inclusion in this distinguished list.

The Role of Quest Diagnostics

Quest Diagnostics operates at the heart of the healthcare ecosystem, emphasizing its critical role in enhancing health outcomes. The company provides diagnostic insights from laboratory results, which empower patients, healthcare providers, and organizations to make informed health decisions. With access to one of the world’s largest databases of clinical lab results, Quest is instrumental in identifying and treating diseases, promoting healthy practices, and enhancing overall healthcare management.

The company serves approximately one in three adult Americans and collaborates with nearly half of all physicians and hospitals across the United States. Its extensive team recognizes the transformative power of diagnostic insights when utilized effectively.

Conclusions

The consistent recognition by Fortune not only highlights Quest Diagnostics’ achievements but also showcases the company’s unwavering dedication to advancing healthcare. As it moves forward, Quest continues its mission to inform and inspire actions that lead to healthier lives globally.

For those looking to learn more about the 2026 Fortune's Most Admired Companies, detailed information can be accessed through the official site.

In summary, Quest Diagnostics exemplifies excellence in healthcare services, reinforcing its status as a vital contributor to global health.